Botanical expertise preventing metabolic disease

Therapeutic areas

Prediabetes, dyslipidemia, arterial hypertension, non-alcoholic fatty liver disease: at Valbiotis, our research targets the main metabolic and cardiovascular risk factors.

Read more

Pipeline

Four plant-based active substances in clinical development to reduce the risk of metabolic and cardiovascular diseases.

Read more

Investors

For news, financial documents and the shareholders’ space.

Read more
Investors

Latest News